These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11798140)

  • 1. Evaluation of dialysis outcomes: experimental versus observational evidence.
    Locatelli F; Andrulli S; D'Amico M
    J Nephrol; 2001; 14 Suppl 4():S101-8. PubMed ID: 11798140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biocompatibility and permeability of dialyzer membranes do not affect anemia, erythropoietin dosage or mortality in japanese patients on chronic non-reuse hemodialysis: a prospective cohort study from the J-DOPPS II study.
    Yokoyama H; Kawaguchi T; Wada T; Takahashi Y; Higashi T; Yamazaki S; Fukuhara S; Akiba T; Akizawa T; Asano Y; Kurokawa K; Saito A;
    Nephron Clin Pract; 2008; 109(2):c100-8. PubMed ID: 18596379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Tentori F; Blayney MJ; Albert JM; Gillespie BW; Kerr PG; Bommer J; Young EW; Akizawa T; Akiba T; Pisoni RL; Robinson BM; Port FK
    Am J Kidney Dis; 2008 Sep; 52(3):519-30. PubMed ID: 18514987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving outcomes for dialysis patients in the international Dialysis Outcomes and Practice Patterns Study.
    Port FK; Pisoni RL; Bommer J; Locatelli F; Jadoul M; Eknoyan G; Kurokawa K; Canaud BJ; Finley MP; Young EW
    Clin J Am Soc Nephrol; 2006 Mar; 1(2):246-55. PubMed ID: 17699213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can convective therapies improve dialysis outcomes?
    Locatelli F; Manzoni C; Cavalli A; Di Filippo S
    Curr Opin Nephrol Hypertens; 2009 Nov; 18(6):476-80. PubMed ID: 19726986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diuretic use, residual renal function, and mortality among hemodialysis patients in the Dialysis Outcomes and Practice Pattern Study (DOPPS).
    Bragg-Gresham JL; Fissell RB; Mason NA; Bailie GR; Gillespie BW; Wizemann V; Cruz JM; Akiba T; Kurokawa K; Ramirez S; Young EW
    Am J Kidney Dis; 2007 Mar; 49(3):426-31. PubMed ID: 17336704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Quantifying dialysis efficiency for middle molecules in haemodialysis and in convective and mixed techniques].
    Casino FG; Lopez T
    G Ital Nefrol; 2008; 25(1):66-75. PubMed ID: 18264920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The MPO Study: just a European HEMO Study or something very different?
    Locatelli F; Gauly A; Czekalski S; Hannedouche T; Jacobson SH; Loureiro A; Martin-Malo A; Papadimitriou M; Passlick-Deetjen J; Ronco C; Vanholder R; Wizemann V;
    Blood Purif; 2008; 26(1):100-4. PubMed ID: 18182806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical dialysis: new problems and new prospects].
    Locatelli F; Manzoni C; Pozzoni P; Pontoriero G; Di Filippo L
    G Ital Nefrol; 2004; 21(2):156-64. PubMed ID: 15351950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal anemia: comparing current Eastern and Western European management practice (ORAMA).
    Wiecek A; Covic A; Locatelli F; Macdougall IC;
    Ren Fail; 2008; 30(3):267-76. PubMed ID: 18350446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Spanish survey on anaemia management].
    Pérez García R
    Nefrologia; 2003; 23(4):300-11. PubMed ID: 14558329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-related quality of life and associated outcomes among hemodialysis patients of different ethnicities in the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Lopes AA; Bragg-Gresham JL; Satayathum S; McCullough K; Pifer T; Goodkin DA; Mapes DL; Young EW; Wolfe RA; Held PJ; Port FK;
    Am J Kidney Dis; 2003 Mar; 41(3):605-15. PubMed ID: 12612984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [DOPPS estimate of patient life years attributable to modifiable hemodialysis practices in Spain].
    Piera L; Cruz JM; Braga-Gresham JL; Eichleay MA; Pisoni RL; Port FK
    Nefrologia; 2007; 27(4):496-504. PubMed ID: 17944588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence-based medicine in the dialysis unit: a few lessons from the USRDS and the NCDS and HEMO trials.
    Briggs JP
    Semin Dial; 2004; 17(2):136-41. PubMed ID: 15043616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dialysis dose and frequency.
    Locatelli F; Buoncristiani U; Canaud B; Köhler H; Petitclerc T; Zucchelli P
    Nephrol Dial Transplant; 2005 Feb; 20(2):285-96. PubMed ID: 15598667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The Dialysis Outcomes and Practice Patterns Study (DOPPS): results of the Italian cohort].
    Pontoriero G; Santoro D; Messina A; Vitiello P; Tasco A; Milei M; Capiferri R; Bellazzi R; Flammini A; Baroni A; Morra M; Cappelli G; Mucaria S; Boggi R; Amico ME; Volzone A; D'andrea T; Paglionico C; Antonucci F; Ivaldi R; Tentori F; Bragg-Gresham J; Pisoni R; Andreucci VE; Locatelli F
    G Ital Nefrol; 2005; 22(5):494-502. PubMed ID: 16267807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of high-flux hemodialysis on renal anemia.
    Ayli D; Ayli M; Azak A; Yüksel C; Kosmaz GP; Atilgan G; Dede F; Abayli E; Camlibel M
    J Nephrol; 2004; 17(5):701-6. PubMed ID: 15593038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New dialysis therapy modalities: what role do they play in the hemodialysis patient's outcome?].
    Mandolfo S; Imbasciati E
    G Ital Nefrol; 2002; 19(1):22-30. PubMed ID: 12165942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin prescription and outcomes in hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Ethier J; Bragg-Gresham JL; Piera L; Akizawa T; Asano Y; Mason N; Gillespie BW; Young EW
    Am J Kidney Dis; 2007 Oct; 50(4):602-11. PubMed ID: 17900460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epoetin alfa use in patients with ESRD: an analysis of recent US prescribing patterns and hemoglobin outcomes.
    Collins AJ; Brenner RM; Ofman JJ; Chi EM; Stuccio-White N; Krishnan M; Solid C; Ofsthun NJ; Lazarus JM
    Am J Kidney Dis; 2005 Sep; 46(3):481-8. PubMed ID: 16129210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.